AVGR
Price
$0.82
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
MBOT
Price
$0.97
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
3 days until earnings call
Ad is loading...

AVGR vs MBOT

Header iconAVGR vs MBOT Comparison
Open Charts AVGR vs MBOTBanner chart's image
Avinger
Price$0.82
Change-$0.00 (-0.00%)
Volume$76.94K
CapitalizationN/A
Microbot Medical
Price$0.97
Change-$0.00 (-0.00%)
Volume$210.54K
CapitalizationN/A
View a ticker or compare two or three
AVGR vs MBOT Comparison Chart
Loading...
AVGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AVGR vs. MBOT commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVGR is a StrongBuy and MBOT is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (AVGR: $0.82 vs. MBOT: $0.97)
Brand notoriety: AVGR and MBOT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AVGR: 23% vs. MBOT: 130%
Market capitalization -- AVGR: $5.28M vs. MBOT: $18.57M
AVGR [@Medical Specialties] is valued at $5.28M. MBOT’s [@Medical Specialties] market capitalization is $18.57M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVGR’s FA Score shows that 1 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • AVGR’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than AVGR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVGR’s TA Score shows that 2 TA indicator(s) are bullish while MBOT’s TA Score has 5 bullish TA indicator(s).

  • AVGR’s TA Score: 2 bullish, 6 bearish.
  • MBOT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MBOT is a better buy in the short-term than AVGR.

Price Growth

AVGR (@Medical Specialties) experienced а -10.19% price change this week, while MBOT (@Medical Specialties) price change was -3.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

AVGR is expected to report earnings on Oct 26, 2023.

MBOT is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($18.6M) has a higher market cap than AVGR($5.28M). MBOT YTD gains are higher at: -41.122 vs. AVGR (-69.742). MBOT has higher annual earnings (EBITDA): -10.75M vs. AVGR (-16.35M). MBOT has more cash in the bank: 8.15M vs. AVGR (5.28M). MBOT has less debt than AVGR: MBOT (245K) vs AVGR (15.4M). AVGR has higher revenues than MBOT: AVGR (7.65M) vs MBOT (0).
AVGRMBOTAVGR / MBOT
Capitalization5.28M18.6M28%
EBITDA-16.35M-10.75M152%
Gain YTD-69.742-41.122170%
P/E RatioN/AN/A-
Revenue7.65M0-
Total Cash5.28M8.15M65%
Total Debt15.4M245K6,286%
FUNDAMENTALS RATINGS
AVGR vs MBOT: Fundamental Ratings
AVGR
MBOT
OUTLOOK RATING
1..100
7616
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9551
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
31n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVGR's Valuation (25) in the Medical Specialties industry is in the same range as MBOT (45) in the Biotechnology industry. This means that AVGR’s stock grew similarly to MBOT’s over the last 12 months.

AVGR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MBOT (100) in the Biotechnology industry. This means that AVGR’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's SMR Rating (98) in the Biotechnology industry is in the same range as AVGR (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to AVGR’s over the last 12 months.

MBOT's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for AVGR (95) in the Medical Specialties industry. This means that MBOT’s stock grew somewhat faster than AVGR’s over the last 12 months.

MBOT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AVGR (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to AVGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVGRMBOT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 14 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Ad is loading...
AVGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

AVGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVGR has been loosely correlated with IMTH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AVGR jumps, then IMTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVGR
1D Price
Change %
AVGR100%
-1.20%
IMTH - AVGR
34%
Loosely correlated
+30.66%
APYX - AVGR
27%
Poorly correlated
+4.96%
MTD - AVGR
27%
Poorly correlated
+0.17%
MBOT - AVGR
27%
Poorly correlated
-1.15%
VTAK - AVGR
25%
Poorly correlated
-9.37%
More

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with MASS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
-1.15%
MASS - MBOT
37%
Loosely correlated
+3.04%
CORBF - MBOT
33%
Loosely correlated
N/A
NVCR - MBOT
32%
Poorly correlated
-0.72%
OTCFF - MBOT
32%
Poorly correlated
N/A
TTOO - MBOT
30%
Poorly correlated
-2.78%
More